摘要
1891年,以参议院讨论的第一道纯净食品和药品综合议案为契机,美国医学会开始介入政府的药品管理。1901年的"机制性"改组是重要的分水岭,美国医学会逐步发展为强大的"医学政治组织"。它通过内部动员,借助《美国医学会杂志》制造社会舆论,外联妇女组织、"黑幕揭发者"以及官僚机构,以多种方式敦促国会颁布了《纯净食品和药品法》和《谢利修正案》,管理国内药品的掺假和贴假商标,规制专利药品制造及贸易。美国医学会与联邦政府的互动、合作优化了转型年代国家与社会的关系,美国医学会也藉对公共卫生事务的参与最终实现了业界利益与公共福利的双赢。
The Senate's consideration of the first general pure food and drug bill in 1891 marks the moment when the American Medical Association(AMA) began to be involved in government drug administration.Its institutional reorganization in 1901 served as a watershed;thereafter it gradually developed into a powerful 'medico-political organization.' The AMA pressed Congress to enact appropriate legislation through internal mobilization and the use of the Journal of the American Medical Association to form public opinion on the one hand,and through liaison with women's organizations,muckrakers,and bureaucratic bodies on the other.The Pure Food and Drug Act of 1906 and the Sherley Amendment of 1912 were intended to govern drug adulteration and mislabeling within the country and to regulate the manufacture of and trade in patent medicines.Interaction and cooperation between the AMA and the Federal government optimized state-society relations in an era of change.The AMA ultimately achieved a win-win situation for professional interests and public welfare through its participation in public health matters.
出处
《历史研究》
CSSCI
北大核心
2009年第1期134-154,共21页
Historical Research
基金
上海市哲社规划课题(项目编号2006BLS003)的阶段性成果
上海市教委重点学科(J50106)的资助